FDA Inspection 1115385 — Kalyan R. Bhamidimarri MD
The FDA completed an inspection of Kalyan R. Bhamidimarri MD on January 16, 2020 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 16, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami, FL (United States)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7498 | 21 CFR 312.66 | Unanticipated problems |
| 7520 | 21 CFR 312.64(b) | Safety reports |
| 7560 | 21 CFR 312.60 | FD-1572, protocol compliance |